Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
54
Number of overlapping holdings
24.5%
% of IBB's 258 holdings also in BBP
88.5%
% of BBP's 65 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 8.4% | 2.1% | 2.1% |
|
AMGEN INC | 8.3% | 2.0% | 2.0% |
|
VERTEX PHARMACEUTICALS INC | 8.2% | 1.7% | 1.7% |
|
INSMED INC | 2.0% | 1.7% | 1.7% |
|
BEIGENE LTD. SPONSORED ADR | 1.7% | 2.3% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to BBP
|
VERTEX PHARMACEUTICALS INC | 6.5% |
|
AMGEN INC | 6.4% |
|
GILEAD SCIENCES INC | 6.3% |
|
REGENERON PHARMACEUTICALS | 4.7% |
|
IQVIA HOLDINGS INC | 3.1% |
 |
ARGENX SE ADR | 2.8% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.7% |
|
ALNYLAM PHARMACEUTICALS INC | 2.7% |
|
NATERA INC | 2.4% |
|
WATERS CORP | 2.3% |
IBB Underweight Relative to BBP
|
INTRA-CELLULAR THERAPIES INC | -2.6% |
|
SAGE THERAPEUTICS INC | -2.1% |
|
TG THERAPEUTICS INC | -2.1% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -1.9% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | -1.7% |
|
SPRINGWORKS THERAPEUTICS, INC. | -1.7% |
|
DYNAVAX TECHNOLOGIES CORP | -1.7% |
|
ARDELYX INC | -1.7% |
|
LIGAND PHARMACEUTICALS-CL B | -1.7% |
|
AXSOME THERAPEUTICS, INC. | -1.7% |